Rob Arbuckle
- Immunology and Allergy top 10%
- Nephrology top 10%
- Dermatology top 5%
- Dermatology and Skin Diseases 6
- Psychiatry and Mental health top 10%
- Ophthalmology top 5%
-
- Ophthalmology and Visual Impairment Studies 11
-
- Health Systems, Economic Evaluations, Quality of Life 6
-
- Respiratory and Cough-Related Research 6
-
- Asthma and respiratory diseases 6
-
- Gastrointestinal motility and disorders 5
-
- Childhood Cancer Survivors' Quality of Life 5
-
- Corneal surgery and disorders 5
- Co-authors
- Linda Abetz‐WebbL. HumphreyNicola WilliamsonNicola BonnerLinda AbetzLaura GrantChloe JohnsonLucy Abraham
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Rob Arbuckle
80 papers receiving 848 citations
Peers
Comparison fields: 5 of 109
- Immunology and Allergy 75
- Nephrology 69
- Dermatology 84
- Psychiatry and Mental health 115
- Ophthalmology 68
Countries citing papers authored by Rob Arbuckle
This map shows the geographic impact of Rob Arbuckle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Arbuckle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Arbuckle more than expected).
Fields of papers citing papers by Rob Arbuckle
This network shows the impact of papers produced by Rob Arbuckle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Arbuckle. The network helps show where Rob Arbuckle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rob Arbuckle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 1 | |
| 11 | Qualitative interviews with patients and caregivers regarding visual function impairments and impacts on vision-dependent activities of daily living and health-related quality of life in RPE65-related Retinitis Pigmentosa and Leber Congenital Amaurosis | 2021 | 6 |
| 12 | 2021 | 1 | |
| 13 | Qualitative exploration of patient and caregiver experiences of visual function impairments and impacts on vision-dependent activities of daily living and health-related quality of life associated with Retinitis Pigmentosa and Leber Congenital Amaurosis in Germany and France | 2021 | 5 |
| 14 | 2020 | 33 | |
| 15 | 2019 | 1 | |
| 16 | 2017 | 14 | |
| 17 | 2017 | 35 | |
| 18 | 2017 | 30 | |
| 19 | 2015 | 9 | |
| 20 | 2011 | 1 |
About Rob Arbuckle
Rob Arbuckle is a scholar working on Family Practice, Ophthalmology and Gastroenterology, having authored 82 papers that have together received 859 indexed citations. Recurring topics across this work include Ophthalmology and Visual Impairment Studies (11 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Respiratory and Cough-Related Research (6 papers), Dermatology and Skin Diseases (6 papers), Asthma and respiratory diseases (6 papers), Gastrointestinal motility and disorders (5 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Corneal surgery and disorders (5 papers). The work is most often cited by research in Immunology and Allergy (75 citations), Nephrology (69 citations) and Dermatology (84 citations). Rob Arbuckle has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Linda Abetz‐Webb, L. Humphrey, Nicola Williamson, Nicola Bonner, Linda Abetz, Laura Grant, Chloe Johnson, Lucy Abraham, Sarah Bentley and Charlotte Panter. Their work appears in journals such as Value in Health, Patient, Quality of Life Research, Ophthalmology and Therapy and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.